ID   SNTB1_HUMAN             Reviewed;         538 AA.
AC   Q13884; A8K9E0; O14912; Q4KMG8;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-JUN-2023, entry version 193.
DE   RecName: Full=Beta-1-syntrophin;
DE   AltName: Full=59 kDa dystrophin-associated protein A1 basic component 1;
DE            Short=DAPA1B;
DE   AltName: Full=BSYN2;
DE   AltName: Full=Syntrophin-2;
DE   AltName: Full=Tax interaction protein 43;
DE            Short=TIP-43;
GN   Name=SNTB1; Synonyms=SNT2B1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), PROTEIN SEQUENCE OF 105-114;
RP   197-208; 339-348 AND 351-355, AND TISSUE SPECIFICITY.
RC   TISSUE=Skeletal muscle;
RX   PubMed=8183929; DOI=10.1073/pnas.91.10.4446;
RA   Ahn A.H., Yoshida M., Anderson M.S., Feener C.A., Selig S., Hagiwara Y.,
RA   Ozawa E., Kunkel L.M.;
RT   "Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein
RT   encoded on chromosome 8q23-24.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:4446-4450(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-19, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-19; 23-31; 145-169; 325-332 AND 364-379, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Histiocytic lymphoma;
RA   Bienvenut W.V., Okada H.;
RL   Submitted (OCT-2005) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 95-538 (ISOFORM 2), AND INTERACTION WITH
RP   HTLV-1 TAX.
RC   TISSUE=Lymphocyte;
RX   PubMed=9482110; DOI=10.1038/sj.onc.1201567;
RA   Rousset R., Fabre S., Desbois C., Bantignies F., Jalinot P.;
RT   "The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the
RT   PDZ domain of cellular proteins.";
RL   Oncogene 16:643-654(1998).
RN   [7]
RP   INTERACTION WITH DMD; DTNA AND UTRN.
RX   PubMed=7844150; DOI=10.1083/jcb.128.3.363;
RA   Ahn A.H., Kunkel L.M.;
RT   "Syntrophin binds to an alternatively spliced exon of dystrophin.";
RL   J. Cell Biol. 128:363-371(1995).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87; SER-219 AND SER-389, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87 AND SER-389, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87; SER-126; THR-214;
RP   SER-219; SER-232 AND SER-389, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Adapter protein that binds to and probably organizes the
CC       subcellular localization of a variety of membrane proteins. May link
CC       various receptors to the actin cytoskeleton and the dystrophin
CC       glycoprotein complex.
CC   -!- SUBUNIT: Monomer and homodimer (Probable). Interacts with the other
CC       members of the syntrophin family SNTA1 and SNTB2; with the sodium
CC       channel proteins SCN4A and SCN5A (By similarity). Interacts with the
CC       viral HTLV-1 TAX protein and with dystrophin protein DMD and related
CC       proteins DTNA and UTRN. Interacts with DTNB (By similarity).
CC       {ECO:0000250, ECO:0000250|UniProtKB:Q99L88, ECO:0000269|PubMed:7844150,
CC       ECO:0000269|PubMed:9482110, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q13884; O95477: ABCA1; NbExp=3; IntAct=EBI-295843, EBI-784112;
CC       Q13884; P11532: DMD; NbExp=4; IntAct=EBI-295843, EBI-295827;
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}; Cytoplasmic side
CC       {ECO:0000250}. Cell junction {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}. Note=In skeletal muscle, it localizes at the cytoplasmic
CC       side of the sarcolemmal membrane and at neuromuscular junctions.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13884-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13884-2; Sequence=VSP_006354, VSP_006355;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:8183929}.
CC   -!- DOMAIN: The PH 1 domain mediates the oligomerization in a calcium
CC       dependent manner. {ECO:0000250}.
CC   -!- DOMAIN: The PDZ domain binds to the last three or four amino acids of
CC       ion channels and receptor proteins. The association with dystrophin or
CC       related proteins probably leaves the PDZ domain available to recruit
CC       proteins to the membrane (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The SU domain binds calmodulin in a calcium-dependent manner.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated by CaM-kinase II. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the syntrophin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L31529; AAA81523.1; -; Genomic_DNA.
DR   EMBL; AK292655; BAF85344.1; -; mRNA.
DR   EMBL; BC098573; AAH98573.1; -; mRNA.
DR   EMBL; AF028828; AAB84253.1; -; mRNA.
DR   CCDS; CCDS6334.1; -. [Q13884-1]
DR   PIR; I59291; I59291.
DR   RefSeq; NP_066301.1; NM_021021.3. [Q13884-1]
DR   RefSeq; XP_011515541.1; XM_011517239.1. [Q13884-2]
DR   PDB; 7P70; X-ray; 2.00 A; A=107-196.
DR   PDB; 7PC4; X-ray; 2.30 A; A=107-196.
DR   PDBsum; 7P70; -.
DR   PDBsum; 7PC4; -.
DR   AlphaFoldDB; Q13884; -.
DR   SMR; Q13884; -.
DR   BioGRID; 112524; 62.
DR   ComplexPortal; CPX-2424; Dystrophin glycoprotein complex, skeletal muscle variant.
DR   ComplexPortal; CPX-2443; Dystrophin glycoprotein complex, neuromuscular junction variant.
DR   ComplexPortal; CPX-2454; Dystrophin glycoprotein complex, retinal outer plexiform layer variant.
DR   ComplexPortal; CPX-2455; Dystrophin glycoprotein complex, retinal inner limiting membrane variant.
DR   DIP; DIP-466N; -.
DR   IntAct; Q13884; 35.
DR   MINT; Q13884; -.
DR   STRING; 9606.ENSP00000378965; -.
DR   GlyGen; Q13884; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q13884; -.
DR   PhosphoSitePlus; Q13884; -.
DR   SwissPalm; Q13884; -.
DR   BioMuta; SNTB1; -.
DR   DMDM; 23822159; -.
DR   EPD; Q13884; -.
DR   jPOST; Q13884; -.
DR   MassIVE; Q13884; -.
DR   MaxQB; Q13884; -.
DR   PaxDb; Q13884; -.
DR   PeptideAtlas; Q13884; -.
DR   ProteomicsDB; 59711; -. [Q13884-1]
DR   ProteomicsDB; 59712; -. [Q13884-2]
DR   TopDownProteomics; Q13884-2; -. [Q13884-2]
DR   Antibodypedia; 13755; 169 antibodies from 26 providers.
DR   DNASU; 6641; -.
DR   Ensembl; ENST00000395601.7; ENSP00000378965.3; ENSG00000172164.15. [Q13884-1]
DR   Ensembl; ENST00000517992.2; ENSP00000431124.1; ENSG00000172164.15. [Q13884-1]
DR   GeneID; 6641; -.
DR   KEGG; hsa:6641; -.
DR   MANE-Select; ENST00000517992.2; ENSP00000431124.1; NM_021021.4; NP_066301.1.
DR   UCSC; uc010mdg.4; human. [Q13884-1]
DR   AGR; HGNC:11168; -.
DR   CTD; 6641; -.
DR   DisGeNET; 6641; -.
DR   GeneCards; SNTB1; -.
DR   HGNC; HGNC:11168; SNTB1.
DR   HPA; ENSG00000172164; Tissue enhanced (liver).
DR   MIM; 600026; gene.
DR   neXtProt; NX_Q13884; -.
DR   OpenTargets; ENSG00000172164; -.
DR   PharmGKB; PA36008; -.
DR   VEuPathDB; HostDB:ENSG00000172164; -.
DR   eggNOG; KOG3551; Eukaryota.
DR   GeneTree; ENSGT00950000182863; -.
DR   HOGENOM; CLU_026406_3_1_1; -.
DR   InParanoid; Q13884; -.
DR   OMA; GENEKQW; -.
DR   OrthoDB; 2906429at2759; -.
DR   PhylomeDB; Q13884; -.
DR   TreeFam; TF317932; -.
DR   PathwayCommons; Q13884; -.
DR   SignaLink; Q13884; -.
DR   SIGNOR; Q13884; -.
DR   BioGRID-ORCS; 6641; 15 hits in 1148 CRISPR screens.
DR   ChiTaRS; SNTB1; human.
DR   GeneWiki; SNTB1; -.
DR   GenomeRNAi; 6641; -.
DR   Pharos; Q13884; Tbio.
DR   PRO; PR:Q13884; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q13884; protein.
DR   Bgee; ENSG00000172164; Expressed in right adrenal gland and 161 other tissues.
DR   ExpressionAtlas; Q13884; baseline and differential.
DR   Genevisible; Q13884; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0016010; C:dystrophin-associated glycoprotein complex; IBA:GO_Central.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; IEA:Ensembl.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   CDD; cd00992; PDZ_signaling; 1.
DR   CDD; cd00821; PH; 1.
DR   CDD; cd01258; PHsplit_syntrophin; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 3.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR041428; PHsplit_syntrophin.
DR   InterPro; IPR015482; Syntrophin.
DR   PANTHER; PTHR10554:SF11; BETA-1-SYNTROPHIN; 1.
DR   PANTHER; PTHR10554; SYNTROPHIN; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF18012; PH_17; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00233; PH; 2.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing; Calcium;
KW   Calmodulin-binding; Cell junction; Cell membrane; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Membrane; Phosphoprotein; Reference proteome;
KW   Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:12665801, ECO:0000269|Ref.5,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   CHAIN           2..538
FT                   /note="Beta-1-syntrophin"
FT                   /id="PRO_0000184009"
FT   DOMAIN          19..298
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          112..195
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          322..433
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          482..538
FT                   /note="SU"
FT   REGION          205..237
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          518..538
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        220..237
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:12665801, ECO:0000269|Ref.5,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:24275569"
FT   MOD_RES         126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         205
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99L88"
FT   MOD_RES         214
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         219
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:24275569"
FT   MOD_RES         232
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99L88"
FT   MOD_RES         389
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         379..382
FT                   /note="RLVH -> SPHP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9482110"
FT                   /id="VSP_006354"
FT   VAR_SEQ         383..538
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9482110"
FT                   /id="VSP_006355"
FT   STRAND          111..116
FT                   /evidence="ECO:0007829|PDB:7P70"
FT   TURN            119..121
FT                   /evidence="ECO:0007829|PDB:7P70"
FT   STRAND          125..130
FT                   /evidence="ECO:0007829|PDB:7P70"
FT   HELIX           131..133
FT                   /evidence="ECO:0007829|PDB:7P70"
FT   STRAND          135..142
FT                   /evidence="ECO:0007829|PDB:7P70"
FT   HELIX           147..151
FT                   /evidence="ECO:0007829|PDB:7P70"
FT   STRAND          158..163
FT                   /evidence="ECO:0007829|PDB:7P70"
FT   HELIX           173..182
FT                   /evidence="ECO:0007829|PDB:7P70"
FT   STRAND          185..193
FT                   /evidence="ECO:0007829|PDB:7P70"
SQ   SEQUENCE   538 AA;  58061 MW;  BF8E7B416D5CF289 CRC64;
     MAVAAAAAAA GPAGAGGGRA QRSGLLEVLV RDRWHKVLVN LSEDALVLSS EEGAAAYNGI
     GTATNGSFCR GAGAGHPGAG GAQPPDSPAG VRTAFTDLPE QVPESISNQK RGVKVLKQEL
     GGLGISIKGG KENKMPILIS KIFKGLAADQ TQALYVGDAI LSVNGADLRD ATHDEAVQAL
     KRAGKEVLLE VKYMREATPY VKKGSPVSEI GWETPPPESP RLGGSTSDPP SSQSFSFHRD
     RKSIPLKMCY VTRSMALADP ENRQLEIHSP DAKHTVILRS KDSATAQAWF SAIHSNVNDL
     LTRVIAEVRE QLGKTGIAGS REIRHLGWLA EKVPGESKKQ WKPALVVLTE KDLLIYDSMP
     RRKEAWFSPV HTYPLLATRL VHSGPGKGSP QAGVDLSFAT RTGTRQGIET HLFRAETSRD
     LSHWTRSIVQ GCHNSAELIA EISTACTYKN QECRLTIHYE NGFSITTEPQ EGAFPKTIIQ
     SPYEKLKMSS DDGIRMLYLD FGGKDGEIQL DLHSCPKPIV FIIHSFLSAK ITRLGLVA
//
